Astellas Pharma Inc.

4503・Prime Market・Pharmaceuticals

Official website

Astellas Pharma Inc.

4503・Prime Market・Pharmaceuticals

Official website

Astellas Pharma Inc.4503

Reference Indicators

Market Cap

39,749¥100M

P/E (Forecast)

13.1x

P/B

2.2x

Dividend Yield (Forecast)

3.64%

ROE

15.9%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245
Cost of Sales	253,009	288,353	292,485	349,206	408,426
Gross Profit	1,043,154	1,230,266	1,311,187	1,563,117	1,730,820
SG&A Expenses	548,840	630,272	740,110	843,032	860,312
Operating Income	155,686	133,029	25,518	41,039	382,633
Pre-tax Income	156,886	132,361	24,969	31,237	376,587
Income Taxes	32,800	33,647	7,924	-19,510	85,013
Net Income	124,086	98,714	17,045	50,747	291,535
Gross Margin	80.5%	81.0%	81.8%	81.7%	80.9%
Operating Margin	12.0%	8.8%	1.6%	2.1%	17.9%
ROA	5.3%	4.0%	0.5%	1.5%	8.2%
ROE	8.5%	6.5%	1.1%	3.4%	15.9%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	0	0	0.0%